SEC 13F Intelligence

Glenview Trust Co / PFE

Glenview Trust Co’s Pfizer Inc Position

Does Glenview Trust Co own Pfizer Inc (PFE)? Yes — 436.4K shares worth $12M (+0.19% of its 13F portfolio) as of Q1 2026, up from 434.9K shares the prior filed quarter.

Position Value
$12M
Q1 2026
Shares
436.4K
% of Portfolio
+0.19%
Quarters Held
30
currently held

Position History PFE

Reported value by quarter
Q4 ’18: $13MQ4 ’18Q1 ’19: $15MQ2 ’19: $16MQ3 ’19: $13MQ4 ’19: $13MQ4 ’19Q1 ’20: $11MQ2 ’20: $13MQ3 ’20: $14MQ4 ’20: $14MQ4 ’20Q1 ’21: $15MQ2 ’21: $18MQ3 ’21: $20MQ4 ’21: $28MQ4 ’21Q1 ’22: $26MQ2 ’22: $27MQ3 ’22: $23MQ4 ’22: $27MQ4 ’22Q1 ’23: $22MQ2 ’23: $20MQ3 ’23: $19MQ4 ’23: $13MQ4 ’23Q1 ’24: $14MQ2 ’24: $15MQ3 ’24: $15MQ4 ’24: $11MQ4 ’24Q1 ’25: $13MQ2 ’25: $11MQ3 ’25: $11MQ4 ’25: $11MQ4 ’25Q1 ’26: $12Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026436.4K$12M+0.19%
Q4 2025434.9K$11M+0.17%
Q3 2025443.9K$11M+0.18%
Q2 2025464.8K$11M+0.19%
Q1 2025493.6K$13M+0.24%
Q4 2024420.5K$11M+0.21%
Q3 2024521.1K$15M+0.29%
Q2 2024520.8K$15M+0.29%
Q1 2024486.8K$14M+0.29%
Q4 2023439.9K$13M+0.31%
Q3 2023565.4K$19M+0.52%
Q2 2023553.4K$20M+0.55%
Q1 2023549.6K$22M+0.67%
Q4 2022530.9K$27M+0.90%
Q3 2022516.8K$23M+0.86%
Q2 2022511.4K$27M+0.98%
Q1 2022500.4K$26M+0.84%
Q4 2021477.0K$28M+0.93%
Q3 2021465.2K$20M+0.77%
Q2 2021453.1K$18M+0.69%
Q1 2021416.1K$15M+0.65%
Q4 2020386.4K$14M+0.66%
Q3 2020385.0K$14M+0.73%
Q2 2020383.3K$13M+0.71%
Q1 2020350.4K$11M+0.79%
Q4 2019336.3K$13M+0.74%
Q3 2019366.6K$13M+0.80%
Q2 2019359.0K$16M+0.97%
Q1 2019341.6K$15M+0.93%
Q4 2018305.2K$13M+0.98%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Glenview Trust Co’s full portfolio or all institutional holders of PFE.